The HIV envelope (Env) is extensively modified with host-derived N-linked glycans. The high density of glycosylation on the viral spike limits enzymatic processing resulting in numerous under-processed oligomannose-type glycans. This extensive glycosylation not only shields conserved regions of the protein from the immune system but also act as targets for HIV broadly neutralizing antibodies (bnAbs). In response to the host immune system, the HIV glycan shield is constantly evolving through mutations affecting both the positions and frequencies of potential N-linked glycans (PNGSs). Here, using longitudinal Env sequences from a clade C infected individual (CAP256), we measure the impact of the shifting glycan shield during HIV infec...
The HIV-1 envelope glycoprotein trimer (Env) is covered by an extensive array of glycans that shield...
Vaccine strategies for the human immunodeficiency virus type 1 (HIV-1) focus on the mimicry of its e...
Viral glycoproteins are a primary target for host antibody responses. However, glycans on viral glyc...
The HIV envelope glycoprotein (Env) is extensively modified with host-derived N-linked glycans. The ...
The envelope spike of HIV-1 employs a 'glycan shield' to protect itself from antibody-mediated neutr...
The envelope spike of HIV-1 employs a 'glycan shield' to protect itself from antibody-mediated neutr...
In recent years the glycan shield of the HIV-1 envelope spike (Env) has emerged as a potential targe...
The HIV-1 envelope glycoprotein (Env) is the sole target for HIV broadly neutralizing antibodies (bn...
The envelope spike of HIV is one of the most highly N-glycosylated structures found in nature. Howev...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
Densely arranged N-linked glycans shield the HIV-1 envelope (Env) trimer from antibody recognition. ...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
<div><p>The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free hole...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free holes large ...
The HIV-1 envelope glycoprotein trimer (Env) is covered by an extensive array of glycans that shield...
Vaccine strategies for the human immunodeficiency virus type 1 (HIV-1) focus on the mimicry of its e...
Viral glycoproteins are a primary target for host antibody responses. However, glycans on viral glyc...
The HIV envelope glycoprotein (Env) is extensively modified with host-derived N-linked glycans. The ...
The envelope spike of HIV-1 employs a 'glycan shield' to protect itself from antibody-mediated neutr...
The envelope spike of HIV-1 employs a 'glycan shield' to protect itself from antibody-mediated neutr...
In recent years the glycan shield of the HIV-1 envelope spike (Env) has emerged as a potential targe...
The HIV-1 envelope glycoprotein (Env) is the sole target for HIV broadly neutralizing antibodies (bn...
The envelope spike of HIV is one of the most highly N-glycosylated structures found in nature. Howev...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
Densely arranged N-linked glycans shield the HIV-1 envelope (Env) trimer from antibody recognition. ...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
<div><p>The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free hole...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free holes large ...
The HIV-1 envelope glycoprotein trimer (Env) is covered by an extensive array of glycans that shield...
Vaccine strategies for the human immunodeficiency virus type 1 (HIV-1) focus on the mimicry of its e...
Viral glycoproteins are a primary target for host antibody responses. However, glycans on viral glyc...